Amyloïd-PET bij patiënten met de ziekte van Alzheimer

Philip Scheltens; Marissa Zwan; Rik Ossenkoppele; Femke Bouwman; Bart N.M. Van Berckel

Amyloïd-PET bij patiënten met de ziekte van Alzheimer

Translated title of the contribution: Amyloid PET imaging in patients with Alzheimer's disease

Philip Scheltens, Marissa Zwan, Rik Ossenkoppele, Femke Bouwman, Bart N.M. Van Berckel

Research output: Contribution to journal › Article › Professional

1 Citation (Scopus)

Abstract

Until a few years ago, amyloid plaques in the brains of patients with Alzheimer's disease could only be demonstrated by means of neuropathological examination. New PET tracers allow for visualisation of these amyloid plaques in living patients. Biological validity and clinical relevance of this technique have been established. Expertise in interpretation of the images and the diagnostic impact is required. Cost effectiveness and added value over existing methods in terms of diagnosis and prognosis are still being investigated.

Translated title of the contribution	Amyloid PET imaging in patients with Alzheimer's disease
Original language	Dutch
Article number	D808
Journal	Nederlands Tijdschrift voor Geneeskunde
Volume	161
Issue number	5
Publication status	Published - 2017

Cite this

@article{34c6019f17214684b581afa0e7dcf7a9,

title = "Amylo{\"i}d-PET bij pati{\"e}nten met de ziekte van Alzheimer",

abstract = "Until a few years ago, amyloid plaques in the brains of patients with Alzheimer's disease could only be demonstrated by means of neuropathological examination. New PET tracers allow for visualisation of these amyloid plaques in living patients. Biological validity and clinical relevance of this technique have been established. Expertise in interpretation of the images and the diagnostic impact is required. Cost effectiveness and added value over existing methods in terms of diagnosis and prognosis are still being investigated.",

author = "Philip Scheltens and Marissa Zwan and Rik Ossenkoppele and Femke Bouwman and {Van Berckel}, {Bart N.M.}",

year = "2017",

language = "Dutch",

volume = "161",

journal = "Nederlands Tijdschrift voor Geneeskunde",

issn = "0028-2162",

publisher = "Vereniging Nederlands Tijdschrift voor Geneeskunde",

number = "5",

}

TY - JOUR

T1 - Amyloïd-PET bij patiënten met de ziekte van Alzheimer

AU - Scheltens, Philip

AU - Zwan, Marissa

AU - Ossenkoppele, Rik

AU - Bouwman, Femke

AU - Van Berckel, Bart N.M.

PY - 2017

Y1 - 2017

N2 - Until a few years ago, amyloid plaques in the brains of patients with Alzheimer's disease could only be demonstrated by means of neuropathological examination. New PET tracers allow for visualisation of these amyloid plaques in living patients. Biological validity and clinical relevance of this technique have been established. Expertise in interpretation of the images and the diagnostic impact is required. Cost effectiveness and added value over existing methods in terms of diagnosis and prognosis are still being investigated.

AB - Until a few years ago, amyloid plaques in the brains of patients with Alzheimer's disease could only be demonstrated by means of neuropathological examination. New PET tracers allow for visualisation of these amyloid plaques in living patients. Biological validity and clinical relevance of this technique have been established. Expertise in interpretation of the images and the diagnostic impact is required. Cost effectiveness and added value over existing methods in terms of diagnosis and prognosis are still being investigated.

UR - http://www.scopus.com/inward/record.url?scp=85014125157&partnerID=8YFLogxK

M3 - Article

SN - 0028-2162

VL - 161

JO - Nederlands Tijdschrift voor Geneeskunde

JF - Nederlands Tijdschrift voor Geneeskunde

IS - 5

M1 - D808

ER -

Amyloïd-PET bij patiënten met de ziekte van Alzheimer

Abstract

Other files and links

Cite this